Abstract:The authors warmly thank the members of the family, nurses of endocrinology unit for recruiting the patients, and laboratory technicians for their assistance. Research ethics: Data were anonymized but the age and the sex were known. The study was carried out according to The Code of Ethics of the World Medical Association (Declaration of Helsinki) and obtained the agreement of the Ethical Committee of the Ethics Committee of the Hospices Civils de Lyon (CNIL N0°920434; GENELIP/ASAP study; clinical trial registration number: NCT03939039, https://clinicaltrials.gov/ct2/show/NCT03939039). Informed consent: This study was carried put according to the French ethic laws. Author contributions: Clinical assessments: PM, GR. Experiments: conception and design: CP, DC, PB, MDF. Performed the experiments: MBR, CP, DC, OM, PB, MDF. Analyzed the data: MBR, CP, DC, OM, PB, MDF. Wrote and reviewed the paper: MBR, PM, CP, DC, PB, MDF. Approved the version to be published, agreed to be accountable for all aspects of the work: all authors. Competing interests: The authors state no conflict of interest. Research funding: None declared. Data availability: Available on request, respecting ethical laws. 1. Marmontel, O, Rollat-Farnier, PA, Wozny, A, Charrière, S, Vanhoye, X, Simonet, T, et al.. Development of a new expanded next-generation sequencing panel for genetic diseases involved in dyslipidemia. Clin Genet 2020;98:589–94. https://doi.org/10.1111/cge.13832. Search in Google Scholar PubMed 2. Rimbert, A, Vanhoye, X, Coulibaly, D, Marrec, M, Pichelin, M, Charrière, S, et al.. Phenotypic differences between polygenic and monogenic hypobetalipoproteinemia. Arterioscler Thromb Vasc Biol 2020;41:e63–71. https://doi.org/10.1161/atvbaha.120.315491. Search in Google Scholar PubMed 3. Bredefeld, C, Hussain, MM, Averna, M, Black, DD, Brin, MF, Burnett, JR, et al.. Guidance for the diagnosis and treatment of hypolipidemia disorders. J Clin Lipidol 2022;16:797–812. https://doi.org/10.1016/j.jacl.2022.08.009. Search in Google Scholar PubMed 4. Witsch-Baumgartner, M, Schwentner, I, Gruber, M, Benlian, P, Bertranpetit, J, Bieth, E, et al.. Age and origin of major Smith-Lemli-Opitz syndrome (SLOS) mutations in European populations. J Med Genet 2008;45:200–9. https://doi.org/10.1136/jmg.2007.053520. Search in Google Scholar PubMed 5. Peng, Y, Myers, R, Zhang, W, Alexov, E. Computational investigation of the missense mutations in DHCR7 gene associated with Smith-Lemli-Opitz syndrome. Int J Mol Sci 2018;19:141. https://doi.org/10.3390/ijms19010141. Search in Google Scholar PubMed PubMed Central 6. Patrono, C, Dionisi-Vici, C, Giannotti, A, Bembi, B, Digilio, MC, Rizzo, C, et al.. Two novel mutations of the human Δ7-sterol reductase (DHCR7) gene in children with Smith-Lemli-Opitz syndrome. Mol Cell Probes 2002;16:315–8. https://doi.org/10.1006/mcpr.2002.0426. Search in Google Scholar PubMed 7. Boland, MR, Tatonetti, NP. Investigation of 7-dehydrocholesterol reductase pathway to elucidate off-target prenatal effects of pharmaceuticals: a systematic review. Pharmacogenomics J 2016;16:411–29. https://doi.org/10.1038/tpj.2016.48. Search in Google Scholar PubMed PubMed Central 8. Porter, FD. Smith-Lemli-Opitz syndrome: pathogenesis, diagnosis and management. Eur J Hum Genet 2008;16:535–41. https://doi.org/10.1038/ejhg.2008.10. Search in Google Scholar PubMed 9. Kelley, RI, Hennekam, RC. The Smith-Lemli-Opitz syndrome. J Med Genet 2000;37:321–35. https://doi.org/10.1136/jmg.37.5.321. Search in Google Scholar PubMed PubMed Central <span class="reference-label d-inlineblock me-4 -Abstract Truncated-

Le syndrome LHIPFOLD : une nouvelle cause traitable de leucopathie cérébrale diffuse de l’adulte associée à un déficit profond en folate intrathécal

New Clinical Characteristics and Novel Pathogenic Variants of Patients with Hereditary Leukodystrophies

La défériprone comme traitement de la neuroferritinopathie, rapport d’une famille

Case Report: Cerebral folate deficiency caused by FOLR1 variant

Implication of folate deficiency in CYP2U1 loss of function

Folate receptor α deficiency – Myelin‐sensitive MRI as a reliable biomarker to monitor the efficacy and long‐term outcome of a new therapeutic approach

The proton-coupled folate transporter (PCFT-SLC46A1) and the syndrome of systemic and cerebral folate deficiency of infancy: Hereditary folate malabsorption

Hereditary Folate Malabsorption with a Novel Mutation on SLC46A1

Localisation hépatique isolée d'une histiocytose langerhansienne : à propos d'un cas

Syndrome un et demi de Fisher révélant une neuroborrhéliose : étude de cas avec revue de littérature

À propos d'un cas clinique de maladie kystique pulmonaire : d'une rareté à la découverte d'un variant génétique inconnu

MYT1L-associated neurodevelopmental disorder: description of 40 new cases and literature review of clinical and molecular aspects

Diagnostic challenge between a frequent polygenic hypocholesterolemia and an unusual Smith Lemli Opitz syndrome related to bi-allelic DHCR7 mutations

Diagnostic intégratif des lymphomes primitifs du système nerveux central (LPSNC) dans le LCR par cytologie, cytométrie de flux, MYD88 et IL-10/6

Conséquences diagnostiques de l’étude clinico-génétique de plus de 2000 patients avec suspicion de dégénérescence lobaire frontotemporale

[Two Cases with Generalized Intracranial Calcification Due to Hereditary Folate Malabsorption and Literature Review].

Expression signature of the Leigh syndrome French-Canadian type

Clinicopathologic Characterization and Abnormal Autophagy of CSF1R -Related Leukoencephalopathy

A new physiological medium uncovers biochemical and cellular alterations in Lesch-Nyhan disease fibroblasts

Exome sequencing identified novel variants in three Chinese patients with 5,10-methenyltetrahydrofolate synthetase deficiency

Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort study